# China NMPA Drug Inspection - Jilin Jichun Pharmaceutical Co., Ltd. - Tongmai Granules

Source: https://www.keypedia.com/records/china_drug_inspection/jilin-jichun-pharmaceutical-co-ltd/cf986914-5f88-4aea-a96e-8d5f1bb65c19
Source feed: China

> China NMPA drug inspection for Jilin Jichun Pharmaceutical Co., Ltd. published March 25, 2020. Drug: Tongmai Granules. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Drug Quality Bulletin of Guangxi Zhuang Autonomous Region Drug Administration (Issue 1, 2020)
- Company Name: Jilin Jichun Pharmaceutical Co., Ltd.
- Publication Date: 2020-03-25
- Drug Name: Tongmai Granules
- Inspection Finding: [Properties], [Inspection] Particle size
- Action Taken: The Guangxi Zhuang Autonomous Region Drug Administration has organized relevant drug supervision and management departments to take necessary control measures against drugs that do not meet the standards and to handle them in accordance with the law.

Company: https://www.keypedia.com/companies/jilin-jichun-pharmaceutical-co-ltd/e9569b3a-d57b-48cc-b11e-42168be35745